XML 27 R15.htm IDEA: XBRL DOCUMENT v2.3.0.15
SEGMENT INFORMATION
9 Months Ended
Sep. 30, 2011
SEGMENT INFORMATION 
SEGMENT INFORMATION

NOTE 11 — SEGMENT INFORMATION

 

The Company has organized its marketing and sales efforts based on four operating segments, which are aggregated into one reportable segment — the development, manufacture and marketing of disposable devices for less invasive surgical procedures.  Each of the Company’s business units has similar economic characteristics, technology, manufacturing processes, customers, distribution and marketing strategies, regulatory environments and shared infrastructures.    These operating segments are Sports Medicine - Americas, Ear Nose and Throat (“ENT”) - Americas, Other — Americas and International.

 

Product sales by operating segment and product area for the periods shown were as follows (in thousands):

 

 

 

Three Months Ended
September 30, 2011

 

Three Months Ended
September 30, 2010

 

 

 

Americas

 

International

 

Total
Product
Sales

 

% Net
Product
Sales

 

Americas

 

International

 

Total
Product
Sales

 

% Net
Product
Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sports Medicine

 

$

33,251

 

$

18,850

 

$

52,101

 

65.6

%

$

40,029

 

$

16,944

 

$

56,972

 

68.6

%

ENT

 

20,046

 

4,851

 

24,897

 

31.3

%

19,379

 

3,636

 

23,016

 

27.9

%

Other

 

658

 

1,776

 

2,434

 

3.1

%

1,016

 

1,913

 

2,929

 

3.5

%

Total product sales

 

$

53,955

 

$

25,477

 

$

79,432

 

100.0

%

$

60,424

 

$

22,493

 

$

82,917

 

100.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

% Net product sales

 

67.9

%

32.1

%

100.0

%

 

 

72.9

%

27.1

%

100.0

%

 

 

 

 

 

Nine Months Ended
September 30, 2011

 

Nine Months Ended
September 30, 2010

 

 

 

Americas

 

International

 

Total
Product
Sales

 

% Net
Product
Sales

 

Americas

 

International

 

Total
Product
Sales

 

% Net
Product
Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sports Medicine

 

$

106,980

 

$

58,987

 

$

165,967

 

66.4

%

$

122,121

 

$

50,012

 

$

172,131

 

68.5

%

ENT

 

62,732

 

13,903

 

76,635

 

30.7

%

58,990

 

10,945

 

69,936

 

27.9

%

Other

 

2,203

 

5,059

 

7,262

 

2.9

%

3,115

 

5,965

 

9,081

 

3.6

%

Total product sales

 

$

171,915

 

$

77,949

 

$

249,864

 

100.0

%

$

184,226

 

$

66,922

 

$

251,148

 

100.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

% Net product sales

 

68.8

%

31.2

%

100.0

%

 

 

73.4

%

26.6

%

100.0

%

 

 

 

Revenues attributed to geographic areas as shown below are based on the country where the Company’s customer is domiciled (in thousands):

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2011

 

2010

 

2011

 

2010

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

50,579

 

$

56,889

 

$

161,427

 

$

175,241

 

Non-United States (1)

 

28,853

 

26,028

 

88,437

 

75,907

 

Total product sales

 

$

79,432

 

$

82,917

 

$

249,864

 

$

251,148

 

 

 

 (1) No additional locations are individually significant.

 

Long-lived assets by geography at the balance sheet dates shown were as follows (in thousands):

 

 

 

September 30,
2011

 

December 31,
2010

 

 

 

 

 

 

 

United States

 

$

22,436

 

$

27,285

 

Costa Rica

 

9,779

 

12,750

 

Other

 

5,522

 

5,729

 

Total long-lived assets

 

$

37,737

 

$

45,764